β-Lactam Antibiotics: Mechanism of Action & Resistance (High-Yield Review)

β-lactam antibiotics are among the most commonly used antimicrobial agents in clinical medicine. This class includes penicillins, cephalosporins, carbapenems, and monobactams, all of which share a common β-lactam ring and a shared mechanism of action.

This post reviews:

• How β-lactams work
• The four major mechanisms of resistance
• Key penicillin subclasses and their clinical spectrum

---

Mechanism of Action of β-Lactam Antibiotics

β-lactam antibiotics work by inhibiting bacterial cell wall synthesis.

• They bind to penicillin-binding proteins (PBPs)
• PBPs function as transpeptidases responsible for cross-linking peptidoglycan chains
• Inhibition prevents proper cell wall formation, leading to cell lysis

This mechanism is effective against both Gram-positive and Gram-negative bacteria, depending on drug structure and permeability.

Key molecular feature:
PBPs contain a serine-based active site motif (SXXK) that binds the β-lactam ring.

---

The Four Major Mechanisms of β-Lactam Resistance

Bacteria can develop resistance to β-lactams through four primary mechanisms:

---

1. Altered Porins (Decreased Drug Entry)

• Primarily affects Gram-negative bacteria
• Loss or mutation of outer membrane porins reduces antibiotic penetration
• Common in organisms such as Pseudomonas aeruginosa and Enterobacterales

---

2. β-Lactamase Production

• Bacterial enzymes that hydrolyze the β-lactam ring
• Inactivates the antibiotic before it can bind PBPs
• Includes:
  • Penicillinases
  • Extended-spectrum β-lactamases (ESBLs)
  • AmpC β-lactamases
  • Carbapenemases

This is the rationale for combining β-lactams with β-lactamase inhibitors such as clavulanate or tazobactam.

---

3. Altered Penicillin-Binding Proteins (PBPs)

• Structural modification of PBPs reduces antibiotic binding affinity
• Leads to functional resistance even when the drug reaches its target
• Classic examples:
  • MRSA → altered PBP2a
  • Streptococcus pneumoniae → mosaic PBPs

---

4. Efflux Pumps

• Active transport systems that pump antibiotics out of the bacterial cell
• Common in Gram-negative organisms
• Often works synergistically with porin loss

---

Penicillin Subclasses and Spectrum of Activity

Penicillin G

• First penicillin, discovered by Alexander Fleming
• Strong activity against Gram-positive organisms
• Limited Gram-negative coverage
• Susceptible to β-lactamases

---

Aminopenicillins (Ampicillin, Amoxicillin)

• Improved Gram-negative coverage
• Retain Gram-positive activity
• β-lactamase sensitive → commonly paired with inhibitors

---

Antistaphylococcal Penicillins (Nafcillin, Oxacillin)

• Resistant to staphylococcal β-lactamase
• Used for MSSA
• No Pseudomonas or significant Gram-negative coverage

---

Antipseudomonal Penicillins (Piperacillin, Ticarcillin)

• Broad Gram-negative coverage, including Pseudomonas
• Also cover many Gram-positives and anaerobes
• Typically combined with β-lactamase inhibitors

---

Take-Home Summary

β-lactam antibiotics inhibit penicillin-binding proteins, preventing peptidoglycan cross-linking. Resistance develops through altered porins, β-lactamase production, altered PBPs, or efflux pumps.

Penicillins & Cephalosporins: Spectrum, Uses, and Key Clinical Pearls

β-lactam antibiotics include penicillins and cephalosporins, which share a β-lactam ring and act by inhibiting penicillin-binding proteins (PBPs) involved in bacterial cell wall synthesis. Differences in structure determine spectrum, resistance, and clinical use.

---

Cephalosporins: Overview

• Contain a β-lactam ring that is more resistant to many β-lactamases than penicillins
• Provide broad Gram-positive and Gram-negative coverage
• Spectrum generally expands toward Gram-negative organisms with higher generations
• Limited activity against Enterococcus, Listeria, and atypicals

---

Penicillin G

• Can be given intravenously or intramuscularly
• Still clinically useful despite resistance
• Effective against:
  • Group A Streptococcus (GAS) – pharyngitis, meningitis
  • Streptococcus pneumoniae (penicillin-sensitive strains)
  • Treponema pallidum (syphilis)

---

Penicillin V (Oral)

• Oral formulation of penicillin
• Commonly used for:
  • Strep pharyngitis (Group A Strep)

---

Benzathine Penicillin G

• Long-acting injectable form of penicillin G
• Used for:
  • Syphilis
  • Rheumatic fever prophylaxis

---

Aminopenicillins: Amoxicillin & Ampicillin

Spectrum

• Expanded Gram-negative coverage compared to penicillin G
• Covers:
  • E. coli
  • Proteus
  • Salmonella
  • Shigella
  • Haemophilus influenzae (resistance common)

Clinical Uses

• Amoxicillin
  • Otitis media
  • Sinusitis
  • Bronchitis
• Ampicillin
  • Drug of choice for Listeria monocytogenes
  • Often combined with gentamicin for synergistic coverage (e.g., meningitis, endocarditis)

---

Antistaphylococcal Penicillins

Includes:

• Methicillin (historical)
• Nafcillin
• Oxacillin
• Dicloxacillin / Cloxacillin (oral options)

Key Points

• Resistant to staphylococcal β-lactamase
• Used for MSSA infections
• Limited Gram-negative coverage
• Methicillin is no longer used clinically but is used in susceptibility testing

Adverse Effect

• Acute interstitial nephritis → discontinue if suspected

---

Antipseudomonal Penicillins

Examples:

• Piperacillin
• Ticarcillin

Spectrum

• Broad Gram-negative coverage, including Pseudomonas aeruginosa
• Active against many Gram-positives and anaerobes
• Generally resistant to many staphylococcal β-lactamases, but not MRSA

---

β-Lactamase Inhibitors

Examples:

• Clavulanic acid
• Sulbactam
• Tazobactam

Mechanism

• Inhibit β-lactamase enzymes
• Protect the accompanying β-lactam antibiotic from degradation

Always Given in Combination

• Amoxicillin–clavulanate
• Piperacillin–tazobactam
• Ampicillin–sulbactam

---

Take-Home Summary

Penicillins and cephalosporins inhibit PBPs to block bacterial cell wall synthesis. Cephalosporins offer broader Gram-negative coverage and increased β-lactamase resistance, while penicillin subclasses are tailored for specific organisms and clinical settings. β-lactamase inhibitors extend activity when resistance is present.

---

β-Lactam / β-Lactamase Inhibitor Combinations & Cephalosporins: A Clinical Guide

β-lactam antibiotics are often paired with β-lactamase inhibitors to overcome bacterial resistance. Cephalosporins further expand coverage through structural modifications that increase stability and spectrum.

---

β-Lactam / β-Lactamase Inhibitor Combinations

β-lactamase inhibitors do not have significant antibacterial activity on their own. Instead, they protect the β-lactam antibiotic from enzymatic degradation.

Common Combinations

• Ampicillin–sulbactam
• Amoxicillin–clavulanate
• Piperacillin–tazobactam

What They Cover

• β-lactamase–producing Gram-positive Staphylococcus (MSSA)
• β-lactamase–producing Gram-negative organisms
• Haemophilus influenzae
• Neisseria species
• Anaerobes

These combinations are commonly used for:

• Skin and soft tissue infections
• Intra-abdominal infections
• Aspiration pneumonia
• Community-acquired infections with resistance concerns

---

Cephalosporins: Advantages Over Penicillins

Cephalosporins have two major advantages over penicillins:

1. Increased resistance to β-lactamases
2. Expanded spectrum of activity, especially Gram-negative organisms

This is due to:

• Modification of the β-lactam ring
• Addition of side chains that enhance penetration and stability

---

Cephalosporin Generations (High-Yield)

General Rule

• Higher generations → more Gram-negative
• Earlier generations → more Gram-positive

---

Second-Generation Cephalosporins

Example:

• Cefuroxime

Coverage & Uses:

• Streptococcus pneumoniae
• Haemophilus influenzae
• Community-acquired pneumonia
• Sinusitis
• Otitis media

📌 Some second-generation agents have anaerobic coverage, making them useful in:

• Surgical prophylaxis
• Abdominal and pelvic infections

---

Third-Generation Cephalosporins

Examples:

• Ceftriaxone
• Ceftazidime (Pseudomonas)

Coverage:

• Strong Gram-negative activity
• Less Gram-positive than earlier generations

Common Uses:

• Severe community-acquired infections
• Meningitis
• Sepsis

---

Fourth-Generation Cephalosporins

Example:

• Cefepime (IV only in the U.S.)

Coverage:

• Gram-positive AND Gram-negative
• Pseudomonas aeruginosa
• More β-lactamase resistant

Used for:

• Hospital-acquired pneumonia
• Severe sepsis

---

Fifth-Generation Cephalosporins

Example:

• Ceftaroline

Key Feature:

• Only cephalosporin with MRSA coverage

Used for:

• Community-acquired pneumonia
• Post-viral pneumonia
• Skin and soft tissue infections

---

Advanced Cephalosporins for Resistant Gram-Negative Infections

Ceftazidime–Avibactam

• Combined with a β-lactamase inhibitor
• Used for multidrug-resistant Gram-negative infections
• Indications:
  • Hospital-acquired pneumonia
  • Ventilator-associated pneumonia
  • Complicated UTIs

---

Cefiderocol (Siderophore Cephalosporin)

• Has a siderophore side chain
• Binds iron and uses bacterial iron transport systems to cross the outer membrane
• Highly resistant to:
  • ESBLs
  • Carbapenemases

Used for:

• Extensively drug-resistant Gram-negative organisms
• Carbapenem-resistant Pseudomonas

---

Carbapenems (Brief Note)

• Broadest β-lactam spectrum
• Cross the outer membrane efficiently
• Resistant to most β-lactamases

⚠️ Adverse effect:

• Decreased seizure threshold, especially with imipenem
• Meropenem has less seizure risk

---

Monobactams

Example:

• Aztreonam

Key Features:

• Only β-lactam in its class
• Binds PBPs of Gram-negative bacteria only
• Covers Pseudomonas
• Minimal cross-reactivity with penicillin allergy

📌 Requires additional Gram-positive coverage

---

Take-Home Summary

β-lactam/β-lactamase inhibitor combinations extend activity against resistant organisms, while cephalosporins expand Gram-negative coverage through structural modifications. Advanced agents like cefiderocol and ceftazidime–avibactam target multidrug-resistant Gram-negative infections in hospital settings.

---